UMIN-CTR History

BACK TOP
UMIN-CTR English Home Glossary (Simple) FAQ Search clinical trials

Name:
UMIN ID:

Unique ID issued by UMIN UMIN000014189
Receipt No. R000016319
Scientific Title Reinduction with lapatinib followed by retreatment with trastuzumab-based therapy after disease progression multi-HER2 targeted therapies in HER2-positive metastatic breast cancer
Date of disclosure of the study information 2014/06/06
Last modified on 2020/06/07 10:32:03

No. Disposal Last modified on Item of update
1 Insert 2014/06/06 15:05:05
2 Update 2015/12/06 10:00:51 Name of person sending information
Name of person sending information
Email
3 Update 2015/12/06 10:04:10 Recruitment status
4 Update 2020/06/07 10:30:16 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code


Last name of contact person
Zip code
Name of primary sponsor
Organization
Organization
Organization
Address
Address
Tel
Email
5 Update 2020/06/07 10:31:28 Recruitment status
Date of IRB
Last follow-up date
6 Update 2020/06/07 10:32:03 Number of participants that the trial has enrolled


Contact us.